Matthew Baker

9.5k total citations
125 papers, 4.1k citations indexed

About

Matthew Baker is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Matthew Baker has authored 125 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Neurology, 59 papers in Physiology and 29 papers in Molecular Biology. Recurrent topics in Matthew Baker's work include Alzheimer's disease research and treatments (50 papers), Parkinson's Disease Mechanisms and Treatments (42 papers) and Amyotrophic Lateral Sclerosis Research (41 papers). Matthew Baker is often cited by papers focused on Alzheimer's disease research and treatments (50 papers), Parkinson's Disease Mechanisms and Treatments (42 papers) and Amyotrophic Lateral Sclerosis Research (41 papers). Matthew Baker collaborates with scholars based in United States, Belgium and United Kingdom. Matthew Baker's co-authors include Rosa Rademakers, Dennis W. Dickson, Keith A. Josephs, Michael Hutton, Bradley F. Boeve, Ronald C. Petersen, Zbigniew K. Wszołek, David S. Knopman, Clifford R. Jack and Jennifer Adamson and has published in prestigious journals such as Science, Blood and PLoS ONE.

In The Last Decade

Matthew Baker

116 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Baker United States 37 2.3k 2.1k 1.0k 1.0k 579 125 4.1k
Anna Karydas United States 31 1.5k 0.7× 1.6k 0.8× 1.3k 1.3× 704 0.7× 838 1.4× 58 3.7k
Zeshan Ahmed United States 32 2.6k 1.2× 2.2k 1.1× 972 1.0× 1.3k 1.3× 507 0.9× 54 4.7k
Pau Pástor Spain 36 2.2k 1.0× 1.2k 0.6× 952 0.9× 790 0.8× 341 0.6× 123 3.6k
Rita Guerreiro United Kingdom 40 1.9k 0.8× 2.6k 1.2× 1.8k 1.8× 1.7k 1.7× 494 0.9× 130 5.6k
Joanne Norton United States 21 1.0k 0.4× 1.4k 0.6× 703 0.7× 630 0.6× 545 0.9× 40 2.6k
Liisa Myllykangas Finland 28 1.7k 0.7× 1.3k 0.6× 1.0k 1.0× 594 0.6× 388 0.7× 71 3.3k
Richard Crook United States 34 1.1k 0.5× 2.5k 1.2× 1.4k 1.4× 627 0.6× 831 1.4× 73 3.9k
Hans Kretzschmar Germany 18 786 0.3× 2.0k 1.0× 1.3k 1.2× 796 0.8× 819 1.4× 28 3.8k
Celeste M. Karch United States 31 846 0.4× 2.5k 1.2× 2.0k 1.9× 1.6k 1.6× 471 0.8× 75 5.0k
Yasumasa Ohyagi Japan 36 1.0k 0.5× 1.1k 0.5× 1.3k 1.2× 556 0.6× 253 0.4× 192 3.8k

Countries citing papers authored by Matthew Baker

Since Specialization
Citations

This map shows the geographic impact of Matthew Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Baker more than expected).

Fields of papers citing papers by Matthew Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Baker. The network helps show where Matthew Baker may publish in the future.

Co-authorship network of co-authors of Matthew Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Baker. A scholar is included among the top collaborators of Matthew Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Baker. Matthew Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Crook, Richard, Peizhou Jiang, Shanu F. Roemer, et al.. (2025). Expanding the spectrum of annexin A11 proteinopathy in frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathologica. 150(1). 52–52.
3.
Noaiseh, Ghaith, Jennifer K. King, Arun S. Varadhachary, et al.. (2024). Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology. Arthritis & Rheumatology. 77(4). 383–389.
4.
Wallace, Zachary S., Guy Katz, Yasmin G. Hernandez‐Barco, & Matthew Baker. (2024). Current and future advances in practice: IgG4-related disease. Rheumatology Advances in Practice. 8(2). rkae020–rkae020. 13 indexed citations
5.
Finch, NiCole A., Mariely DeJesus‐Hernandez, Jazmyne L. Jackson, et al.. (2024). Targeted long-read sequencing to quantify methylation of the C9orf72 repeat expansion. Molecular Neurodegeneration. 19(1). 99–99. 4 indexed citations
6.
Kuswanto, Wilson & Matthew Baker. (2024). Repurposing drugs for the treatment of osteoarthritis. Osteoarthritis and Cartilage. 32(8). 886–895. 14 indexed citations
7.
Koga, Shunsuke, Michael A. Metrick, Lawrence I. Golbe, et al.. (2023). Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathologica Communications. 11(1). 88–88. 7 indexed citations
8.
Baker, Matthew, Khushboo Sheth, Rong Lü, et al.. (2023). Increased risk of osteoarthritis in patients with atopic disease. Annals of the Rheumatic Diseases. 82(6). 866–872. 13 indexed citations
9.
Baker, Matthew, Sarah Kavanagh, Stanley Cohen, et al.. (2023). A Randomized, Double‐Blind, Sham‐Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis. Arthritis & Rheumatology. 75(12). 2107–2115. 14 indexed citations
10.
Baker, Matthew, Yiwen Wang, Yuhan Liu, et al.. (2023). A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis. Lara D. Veeken. 63(5). 1297–1304. 10 indexed citations
11.
Baker, Matthew, Khushboo Sheth, Yuhan Liu, et al.. (2023). Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea. JAMA Network Open. 6(3). e233646–e233646. 20 indexed citations
12.
Koga, Shunsuke, et al.. (2021). Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology. Neuropathology and Applied Neurobiology. 48(2). e12778–e12778. 20 indexed citations
13.
Buciuc, Marina, Jennifer L. Whitwell, Matthew Baker, et al.. (2021). Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition. Neuropathology and Applied Neurobiology. 47(7). 1050–1059. 11 indexed citations
14.
Heckman, Michael G., Patrick W. Johnson, Matthew Baker, et al.. (2021). Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease. Neurology. 96(13). e1755–e1760.
15.
Spinner, Michael A., Matthew Baker, Ranjana H. Advani, et al.. (2021). Increased double-negative αβ+ T-cells reveal adult-onset autoimmune lymphoproliferative syndrome in a patient with IgG4-related disease. Haematologica. 107(1). 347–350. 1 indexed citations
16.
Shang, Pei, Mingqin Zhu, Matthew Baker, et al.. (2020). Mechanical ventilation in Guillain–Barré syndrome. Expert Review of Clinical Immunology. 16(11). 1053–1064. 24 indexed citations
17.
Sakae, Nobutaka, Shanu F. Roemer, Kevin F. Bieniek, et al.. (2019). Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations. Annals of Clinical and Translational Neurology. 6(9). 1782–1796. 20 indexed citations
18.
Coon, Elizabeth A., Jasper R. Daube, Mariely DeJesus‐Hernandez, et al.. (2012). Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(2). 132–137. 7 indexed citations
19.
Boeve, Bradley F., Brendon Boot, Carolyn Orr, et al.. (2011). Clinical Characterization of a Kindred With a Novel 12-Octapeptide Repeat Insertion in the Prion Protein Gene. Archives of Neurology. 68(9). 1165–1165. 21 indexed citations
20.
Lewis, Patrick A., Siân C. Piper, Matthew Baker, et al.. (2001). Expression of BRI–amyloid β peptide fusion proteins: a novel method for specific high-level expression of amyloid β peptides. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537(1). 58–62. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Karydas Breakdown of academic impact, for papers by Zeshan Ahmed Breakdown of academic impact, for papers by Pau Pástor Breakdown of academic impact, for papers by Rita Guerreiro Breakdown of academic impact, for papers by Joanne Norton Breakdown of academic impact, for papers by Liisa Myllykangas Breakdown of academic impact, for papers by Richard Crook Breakdown of academic impact, for papers by Hans Kretzschmar Breakdown of academic impact, for papers by Celeste M. Karch Breakdown of academic impact, for papers by Yasumasa Ohyagi
Rankless by CCL
2026